Schedule 13G ownership disclosure
TRAWS PHARMA INC
Common Stock, par value $0.01 per share · CUSIP: 68232V884
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 886,887 · Class: 9.99%
- Joseph Edelman
Shares: 886,887 · Class: 9.99%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 886,887 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-282836
- Form type
- SCHEDULE 13G/A
- Filer
- PERCEPTIVE ADVISORS LLC
- CIK
- CIK 1224962
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership